Condition

Stage III Mycosis Fungoides/Sezary Syndrome

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions5

Lead sponsors shown2

Clinical trials

2 shown

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesNCT01273766 · 2011-01-01

COMPLETED

RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsNCT01158274 · 2010-06-01

COMPLETED

Common interventions

laboratory biomarker analysisOTHER2capecitabineDRUG1deferasiroxDRUG1enzyme-linked immunosorbent assayOTHER1gamma-secretase/Notch signalling pathway inhibitor RO4929097DRUG1

Leading sponsors

National Cancer Institute (NCI)1Wake Forest University Health Sciences1

Trial status mix

COMPLETED2

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.